ONCOMED PHARMACEUTICALS INC


Updates from The Motley Fool

Latest updates on OncoMed Pharmaceuticals from Fool.com.


Stock Performance

OMED vs. S&P 500 | 2 Year Performance
View Interactive OMED Charts
Sponsored by

Key Data Points

Primary metrics and data points about OncoMed Pharmaceuticals.
Current Price: $10.36
Prev Close: $10.73
Open: $11.05
Bid: $10.08
Ask: $12.10
Day's Range: $10.30 - $11.19
52wk Range: $8.42 - $23.98
Volume: 264,106
Avg Vol 195,694
Market Cap: $311.93M
P/E (ttm): -3.12
EPS (ttm): -$3.44
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about OncoMed Pharmaceuticals.
CAPS Rating 4 out of 5
 
29 Outperform
3 Underperform
CAPS All Stars
 
3 Outperform
1 Underperform

How do you think OncoMed Pharmaceuticals will perform against the market?



You pick for OncoMed Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul J. Hastings, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for OncoMed Pharmaceuticals.

ONCOMED PHARMACEUTICALS INC

  • Exchange: NASDAQ